Hepatitis Monthly

Published by: Kowsar

Serum Thrombopoietin Levels and Its Relationship With Thrombocytopenia in Patients With Cirrhosis

Tuncer Temel 1 , * , Dondu Uskudar Cansu 2 , Halide Edip Temel 3 and Aysegul Harmanc Ozakyol 1
Authors Information
1 Department of Internal Medicine, Division of Gastroenterology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
2 Department of Internal Medicine, Division of Rheumotology, Faculty of Medicine, Eskişehir Osmangazi University, Eskisehir, Turkey
3 Biochemistry Department, Pharmacy Faculty, Anadolu University, Eskisehir, Turkey
Article information
  • Hepatitis Monthly: May 01, 2014, 14 (5); e18556
  • Published Online: May 5, 2014
  • Article Type: Research Article
  • Received: March 25, 2014
  • Revised: March 22, 2014
  • Accepted: May 13, 2014
  • DOI: 10.5812/hepatmon.18556

To Cite: Temel T, Cansu D U, Temel H E, Ozakyol A H. Serum Thrombopoietin Levels and Its Relationship With Thrombocytopenia in Patients With Cirrhosis, Hepat Mon. 2014 ; 14(5):e18556. doi: 10.5812/hepatmon.18556.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Eckman JR. Hepatology. A Textbook of Liver Disease,. 1996; : 685-90
  • 2. Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: A review. World J Gastroenterol. 2014; 20(10): 2595-605[DOI][PubMed]
  • 3. Sanjo A, Satoi J, Ohnishi A, Maruno J, Fukata M, Suzuki N. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol. 2003; 18(6): 638-44[PubMed]
  • 4. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 1995; 86(2): 419-31[PubMed]
  • 5. Shimada Y, Kato T, Ogami K, Horie K, Kokubo A, Kudo Y, et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol. 1995; 23(13): 1388-96[PubMed]
  • 6. Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Längle F, et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? Journal of Hepatology. 1997; 27(1): 127-31[DOI]
  • 7. Martin T3, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med. 1997; 127(4): 285-8[PubMed]
  • 8. Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, et al. Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest. 1998; 28(9): 755-9[PubMed]
  • 9. Freni MA, Spadaro A, Ajello A, Barbaro E, Scaffidi M, Alessi N, et al. Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size. Hepatogastroenterology. 2002; 49(47): 1382-5[PubMed]
  • 10. Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M, Suzuki F, et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999; 94(7): 1918-22[DOI][PubMed]
  • 11. Koruk M, Onuk MD, Akcay F, Savas MC. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts. Hepatogastroenterology. 2002; 49(48): 1645-8[PubMed]
  • 12. Giannini E, Botta F, Borro P, Malfatti F, Fumagalli A, Testa E, et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol. 2003; 98(11): 2516-20[DOI][PubMed]
  • 13. Rios R, Sangro B, Herrero I, Quiroga J, Prieto J. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol. 2005; 100(6): 1311-6[DOI][PubMed]
  • 14. Espanol I, Gallego A, Enriquez J, Rabella N, Lerma E, Hernandez A, et al. Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: role of thrombopoietin. Hepatogastroenterology. 2000; 47(35): 1404-6[PubMed]
  • 15. Ozer B, Serin E, Sezgin N, Cosar A, Guclu M, Gur G, et al. Thrombopoietin or interleukin-6 has no effect on thrombocytopenia of cirrhosis. Hepatogastroenterology. 2007; 54(76): 1187-91[PubMed]
  • 16. Giannini E, Borro P, Botta F, Fumagalli A, Malfatti F, Podestà E, et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. Journal of Hepatology. 2002; 37(5): 572-7[DOI]
  • 17. Schoffski P, Tacke F, Trautwein C, Martin MU, Caselitz M, Hecker H, et al. Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease. Liver. 2002; 22(2): 114-20[PubMed]
  • 18. Akyuz F, Yekeler E, Kaymakoglu S, Horasanli S, Ibrisim D, Demir K, et al. The role of thrombopoietin and spleen volume in thrombocytopenia of patients with noncirrhotic and cirrhotic portal hypertension. Turk J Gastroenterol. 2007; 18(2): 95-9[PubMed]
  • 19. Okubo M, Shiota G, Kawasaki H. Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma. Clin Sci (Lond). 2000; 99(3): 207-14[PubMed]
  • 20. Aref S, Mabed M, Selim T, Goda T, Khafagy N. Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia. Hematology. 2004; 9(5-6): 351-6[DOI][PubMed]
  • 21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8): 646-9[PubMed]
  • 22. Hallen A, Nilsson IM. Coagulation Studies in Liver Disease. Thromb Diath Haemorrh. 1964; 11: 51-63[PubMed]
  • 23. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest. 1969; 48(6): 963-74[DOI][PubMed]
  • 24. Marongiu F, Mamusa AM, Mameli G, Mulas G, Cambuli AB, Piga M, et al. Thrombocytopenia and liver cirrhosis evidence for relationship between platelet count, spleen size and hepatic synthetic activity. Thrombosis Research. 1987; 45(3): 275-8[DOI]
  • 25. Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, et al. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011; 54(5): 894-900[DOI][PubMed]
  • 26. Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, et al. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol. 2007; 22(1): 112-8[DOI][PubMed]
  • 27. Shimodaira S, Ishida F, Ichikawa N, Tahara T, Kato T, Kodaira H, et al. Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemost. 1996; 76(4): 545-8[PubMed]
  • 28. Berman L, Axelrod AR. The blood and bone marrow in patients with cirrhosis of the liver. Blood. 1949; 4(5): 511-33[PubMed]
  • 29. Sheikh MY, Raoufi R, Atla PR, Riaz M, Oberer C, Moffett MJ. Prevalence of cirrhosis in patients with thrombocytopenia who receive bone marrow biopsy. Saudi J Gastroenterol. 2012; 18(4): 257-62[DOI][PubMed]
  • 30. Barsam SJ, Psaila B, Forestier M, Page LK, Sloane PA, Geyer JT, et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 2011; 117(21): 5723-32[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments